Relay Therapeutics to Participate in Three Upcoming Investor Conferences
Relay Therapeutics, Inc. (RLAY) will participate in three upcoming fireside chats at major healthcare conferences in March 2024. The company aims to showcase its innovative approach to drug discovery using computational and experimental technologies.
02/26/2024 - 04:05 PM
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc.
TD Cowen’s 44th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 a.m. ET Leerink Partners’ 2024 Global Biopharma Conference on Monday, March 11, 2024 at 10:40 a.m. ET Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 7:30 a.m. ET The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations
About Relay Therapeutics
Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com follow us on Twitter
Contact: mgoulart@relaytx.com
Media: dan@1abmedia.com
When will Relay Therapeutics (RLAY) participate in the TD Cowen's 44th Annual Health Care Conference?
Relay Therapeutics will participate in TD Cowen's 44th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 a.m. ET.
What is the focus of Relay Therapeutics (RLAY) in transforming the drug discovery process?
Relay Therapeutics focuses on transforming the drug discovery process by combining leading-edge computational and experimental technologies.
Where can investors access the webcast of Relay Therapeutics' (RLAY) fireside chats?
Investors can access the webcast of Relay Therapeutics' fireside chats on the company's website under Events in the News & Events section through the provided link.
How long will the archived replay of the webcast be available?
The archived replay of the webcast will be available for up to 30 days following the event.
RLAY Rankings
#5186 Ranked by Stock Gains
RLAY Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Pharmaceuticals: Major, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Cambridge
About RLAY
relay therapeutics is building the world’s first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. by placing protein motion at the heart of drug discovery, relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients. headquartered in cambridge, mass., relay therapeutics is a private company launched in 2016. to date, relay therapeutics has raised $120m in financing from third rock ventures, bvf partners, gv (formerly google ventures), an affiliate of d.e. shaw research, casdin capital, ecor1 capital, section 32 and alexandria venture investments. our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. if you're creative, collaborative and passionate
